Mycenax Biotech Inc. is a prominent provider in the biotechnology sector, offering high-quality and flexible Contract Development and Manufacturing Organization (CDMO) services. The company operates a PIC/S GMP compliant facility and boasts a state-of-the-art research and development team. Mycenax specialises in developing biologics, including small peptides, fusion proteins, and monoclonal antibodies, as well as providing comprehensive solutions in cell and gene therapy.

Services include:
– Biologics
– Cell and Gene Therapy
– Development of small peptides
– Manufacturing of fusion proteins
– Production of monoclonal antibodies

Mycenax Biotech Inc. is dedicated to delivering innovative and reliable solutions to the pharmaceutical industry, ensuring the highest standards of quality and flexibility. For more information, please visit mycenax.com.tw.